{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:40:48Z","timestamp":1786621248550,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nucmedbio.2026.109656","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:28:38Z","timestamp":1782919718000},"page":"109656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Electroless semi-automatic synthesis of 225Ac-labeled PSMA-derivatives for clinical application and evaluation of rechelation capability"],"prefix":"10.1016","volume":"158-159","author":[{"given":"Marc","family":"Pretze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Gehlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Mamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"Bundschuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2026.109656_bb0005","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/annonc\/mdz270","article-title":"Advances in targeted alpha therapy for prostate cancer","volume":"30","author":"De Vincentis","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nucmedbio.2025.109044","article-title":"Radiobiological effect of alpha particles. The scientific basis of targeted alpha-particle therapy","volume":"146-147","author":"Cruz-Nova","year":"2025","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.nucmedbio.2011.10.015","article-title":"Influence of cations on the complexation yield of DOTATATE with yttrium and lutetium: a perspective study for enhancing the 90Y and 177Lu labeling conditions","volume":"39","author":"Asti","year":"2012","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.apradiso.2013.08.010","article-title":"Influence of metal ions on the 68Ga-labeling of DOTATATE","volume":"82","author":"Oehlke","year":"2013","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0025","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7150\/thno.14338","article-title":"Preliminary therapy evaluation of 225Ac-DOTA-c(RGDyK) demonstrates that Cerenkov radiation derived from 225Ac daughter decay can be detected by optical imaging for in vivo tumor visualization","volume":"6","author":"Pandya","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00259-018-4167-0","article-title":"225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study","volume":"46","author":"Sathekge","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0035","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2967\/jnumed.116.178673","article-title":"225Ac-PSMA-617 for PSMA-targeted \u03b1-radiation therapy of metastatic castration-resistant prostate cancer","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(23)00638-1","article-title":"Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH act): a multicentre, retrospective study","volume":"25","author":"Sathekge","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0045","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/chem.201905202","article-title":"Establishing radiolanthanum chemistry for targeted nuclear medicine applications","volume":"26","author":"Aluicio-Sarduy","year":"2020","journal-title":"Chemistry"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0050","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1021\/acs.bioconjchem.0c00171","article-title":"225Ac-H4py4pa for targeted alpha therapy","volume":"32","author":"Li","year":"2021","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0055","doi-asserted-by":"crossref","first-page":"14712","DOI":"10.1002\/anie.201709532","article-title":"An eighteen-membered macrocyclic ligand for Actinium-225 targeted alpha therapy","volume":"56","author":"Thiele","year":"2017","journal-title":"Angew Chem Int Ed Eng"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0060","first-page":"336","article-title":"Actinium-225 for targeted \u03b1 therapy: coordination chemistry and current chelation approaches","volume":"33","author":"Thiele","year":"2018","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0065","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1021\/acs.inorgchem.9b01277","article-title":"Implementing f-block metal ions in medicine: tuning the size selectivity of expanded macrocycles","volume":"58","author":"Thiele","year":"2019","journal-title":"Inorg Chem"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081974","article-title":"Towards targeted alpha therapy with Actinium-225: chelators for mild condition radiolabeling and targeting PSMA\u2014A proof of concept study","volume":"13","author":"Reissig","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ph16111622","article-title":"Theranostic imaging surrogates for targeted alpha therapy: Progress in production, purification, and applications","volume":"16","author":"Nelson","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8160134","article-title":"Labelling of 90Y- and 177Lu-DOTA-bioconjugates for targeted radionuclide therapy: a comparison among manual, semiautomated, and fully automated synthesis","volume":"2017","author":"Iori","year":"2017","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0085","first-page":"107","article-title":"Lutetium-177 DOTATATE production with an automated radiopharmaceutical synthesis system","volume":"3","author":"Aslani","year":"2015","journal-title":"Asia Oceania J Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0090","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/pros.23974","article-title":"Influence of short-term dexamethasone on the efficacy of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer","volume":"80","author":"Derlin","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0095","first-page":"72","article-title":"Automated module radiolabeling of peptides and antibodies with gallium-68, lutetium-177 and iodine-131","volume":"27","author":"De Decker","year":"2012","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jlcr.3889","article-title":"Automated radiosynthesis of [68Ga]Ga-PSMA-11 and [177Lu]Lu-PSMA-617 on the iPHASE MultiSyn module for clinical applications","volume":"64","author":"Wichmann","year":"2021","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.nucmedbio.2020.07.008","article-title":"Automated production of [18F]SiTATE on a Scintomics GRP platform for PET\/CT imaging of neuroendocrine tumors","volume":"88\u201389","author":"Lindner","year":"2020","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12149-019-01376-3","article-title":"The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival","volume":"33","author":"Acar","year":"2019","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jlcr.3846","article-title":"Automated synthesis of 68Ga\/177Lu-PSMA on the Trasis miniAllinOne","volume":"63","author":"S\u00f8rensen","year":"2020","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0120","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.2967\/jnumed.115.171249","article-title":"Comprehensive quality control of the ITG 68Ge\/68Ga generator and synthesis of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical imaging","volume":"57","author":"Amor-Coarasa","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ph14070652","article-title":"Ac-EAZY! Towards GMP-compliant module syntheses of 225Ac-labeled peptides for clinical application","volume":"14","author":"Pretze","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0130","doi-asserted-by":"crossref","first-page":"20699","DOI":"10.1021\/acs.inorgchem.3c01983","article-title":"Equilibrium thermodynamics of macropa complexes with selected metal isotopes of radiopharmaceutical interest","volume":"62","author":"Blei","year":"2023","journal-title":"Inorg Chem"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0135","doi-asserted-by":"crossref","first-page":"19925","DOI":"10.1021\/acs.est.4c06189","article-title":"The global threat from the irreversible accumulation of Trifluoroacetic acid (TFA)","volume":"58","author":"Arp","year":"2024","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41181-023-00191-6","article-title":"Improved quality control of [177Lu]Lu-PSMA I&T","volume":"8","author":"Kraihammer","year":"2023","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28237696","article-title":"Quality assurance investigations and impurity characterization during upscaling of [177Lu]Lu-PSMA(I&T)","volume":"28","author":"Schmitl","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0150","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1021\/bc700341x","article-title":"Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature","volume":"19","author":"Velikyan","year":"2008","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27041713","article-title":"Efficient 68Ga labeling of a B7-H3-targeting Affibody molecule via acyclic Tris(hydroxypyridinone) Chelator: effects on biodistribution in a preclinical model","volume":"27","author":"Tolmachev","year":"2026","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0160","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s00259-011-2023-6","article-title":"Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis","volume":"39","author":"Essler","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48298-8","article-title":"The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrier","volume":"9","author":"Kruijff","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12885-024-11900-y","article-title":"Evaluation of the tolerability and safety of [225Ac]ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study","volume":"24","author":"Ling","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nucmedbio.2026.109656_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ph13040076","article-title":"Atomic nanogenerators in targeted alpha therapies: Curie\u2019s legacy in modern cancer management","volume":"13","author":"Roscher","year":"2020","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:25:57Z","timestamp":1786620357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805126000557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":35,"alternative-id":["S0969805126000557"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109656","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electroless semi-automatic synthesis of 225Ac-labeled PSMA-derivatives for clinical application and evaluation of rechelation capability","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109656"}}